Denis Eunan O'donnell

Denis Eunan O'donnell's AcademicInfluence.com Rankings

Philosophy

#5373

World Rank

#8148

Historical Rank

Logic

#2661

World Rank

#3682

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Denis Eunan O'donnell's Degrees

Doctorate Respiratory Medicine University of Manchester

Why Is Denis Eunan O'donnell Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Denis Eunan O'donnell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. (2006) (1877)
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. (2012) (1286)
Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. (1999) (1038)
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. (2001) (1030)
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD (2004) (879)
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. (2007) (683)
Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. (1993) (560)
Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. (1998) (558)
Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. (1999) (486)
Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial (2005) (458)
Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. (1997) (443)
Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease (2007) (399)
Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. (2006) (386)
Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. (2007) (354)
Recommendations on the use of exercise testing in clinical practice (2006) (347)
Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. (2008) (335)
Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. (2005) (331)
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. (2003) (328)
Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. (2001) (325)
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement (2016) (292)
Obesity and the lung: 5 · Obesity and COPD (2008) (287)
ERS statement on respiratory muscle testing at rest and during exercise (2019) (282)
Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. (2006) (245)
Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. (2002) (239)
American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. (2010) (235)
Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. (2011) (233)
Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. (2002) (232)
Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. (2006) (232)
General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. (1998) (225)
Physiological changes during symptom recovery from moderate exacerbations of COPD (2005) (220)
COPD exacerbations · 3: Pathophysiology (2006) (214)
The major limitation to exercise performance in COPD is dynamic hyperinflation. (2008) (202)
The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. (1995) (199)
Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. (1997) (198)
Mechanisms of activity-related dyspnea in pulmonary diseases (2009) (195)
Dyspnea and Activity Limitation in COPD: Mechanical Factors (2007) (192)
Physiology and consequences of lung hyperinflation in COPD (2006) (185)
Respiratory sensation during chest wall restriction and dead space loading in exercising men. (2000) (173)
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. (2008) (171)
Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders. (2016) (170)
Ventilatory and perceptual responses to cycle exercise in obese women. (2007) (169)
Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance. (2015) (167)
Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. (1996) (166)
The Clinical Importance of Dynamic Lung Hyperinflation in COPD (2006) (161)
Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. (1993) (159)
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. (2011) (156)
Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? (2011) (156)
Ventilatory limitations in chronic obstructive pulmonary disease. (2001) (152)
Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. (2012) (150)
Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. (2011) (141)
Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation (2013) (140)
Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. (1998) (136)
Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline. (2010) (129)
Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? (2000) (124)
Ventilatory assistance improves exercise endurance in stable congestive heart failure. (1999) (124)
Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD (2006) (123)
Chronic obstructive pulmonary disease: clinical integrative physiology. (2014) (121)
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD (2014) (114)
Breathlessness in patients with chronic airflow limitation. Mechanisms and management. (1994) (112)
Exercise ventilatory inefficiency in mild to end-stage COPD (2014) (112)
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. (2004) (110)
Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD (2014) (107)
Recent advances in dyspnea. (2015) (104)
Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? (2013) (104)
Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD (2009) (102)
Lung Hyperinflation and Its Reversibility in Patients with Airway Obstruction of Varying Severity (2010) (100)
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD (2008) (100)
Effects of BMI on static lung volumes in patients with airway obstruction. (2011) (98)
Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. (2006) (95)
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. (2012) (95)
Diagnosis, assessment, and phenotyping of COPD: beyond FEV1 (2016) (94)
Inspiratory muscle training reduces diaphragm activation and dyspnea during exercise in COPD. (2018) (93)
Effects of pregnancy, obesity and aging on the intensity of perceived breathlessness during exercise in healthy humans (2009) (91)
Sex differences in the perceived intensity of breathlessness during exercise with advancing age. (2008) (88)
Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. (1992) (87)
No room to breathe: the importance of lung hyperinflation in COPD (2013) (87)
Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. (2012) (85)
Breathlessness during induced lung hyperinflation in asthma: the role of the inspiratory threshold load. (1995) (83)
Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. (2012) (82)
Dyspnea in COPD: New Mechanistic Insights and Management Implications (2019) (82)
When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. (2014) (80)
Effects of human pregnancy on the ventilatory chemoreflex response to carbon dioxide. (2005) (79)
Impact of Pulmonary Rehabilitation on the Major Dimensions of Dyspnea in COPD (2013) (79)
Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases (2017) (78)
Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing (2016) (78)
Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. (2009) (78)
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD (2008) (77)
Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD (2017) (75)
Effect of obesity on respiratory mechanics during rest and exercise in COPD. (2011) (75)
Sex differences in exertional dyspnea in patients with mild COPD: Physiological mechanisms (2011) (75)
Physiological and clinical relevance of exercise ventilatory efficiency in COPD (2017) (71)
Lung hyperinflation in COPD: applying physiology to clinical practice (2015) (69)
Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease. (2017) (69)
Mechanisms of exertional dyspnea in patients with cancer. (2008) (68)
Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample (2012) (67)
Roflumilast—An oral anti-inflammatory treatment for chronic obstructive pulmonary disease: A randomised controlled trial: The Lancet 2005;366(9485):563–71. (2005) (64)
Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease A Randomized Trial (2007) (63)
Incident opioid drug use and adverse respiratory outcomes among older adults with COPD (2016) (61)
Mechanisms of exertional dyspnoea in symptomatic smokers without COPD (2016) (61)
Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment (2014) (61)
Respiratory function and the obesity paradox (2010) (61)
Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. (2014) (60)
Chemoreflex control of breathing during wakefulness in healthy men and women. (2005) (60)
Physiological mechanisms of hyperventilation during human pregnancy (2008) (59)
Combined Effects of Obesity and Chronic Obstructive Pulmonary Disease on Dyspnea and Exercise Tolerance (2009) (58)
Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions (2019) (57)
Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD? (2014) (57)
Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study (2016) (56)
Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary Disease (2012) (55)
Dyspnea: Mechanisms, Measurement and Management (2005) (55)
Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. (2016) (55)
Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD (2009) (54)
CTS position statement: Pharmacotherapy in patients with COPD—An update (2017) (53)
Excess Ventilation in Chronic Obstructive Pulmonary Disease‐Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance (2017) (50)
Chemical and mechanical adaptations of the respiratory system at rest and during exercise in human pregnancy. (2007) (49)
Dietary nitrate supplementation and exercise tolerance in patients with heart failure with reduced ejection fraction. (2017) (48)
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis. (2017) (47)
Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. (2009) (47)
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations (2016) (46)
Effects of obesity on perceptual and mechanical responses to bronchoconstriction in asthma. (2010) (45)
The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. (2017) (45)
Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study. (2019) (43)
Mechanical ventilatory constraints during incremental cycle exercise in human pregnancy: implications for respiratory sensation (2008) (43)
Activity restriction in mild COPD: a challenging clinical problem (2014) (42)
Effects of dead space loading on neuro-muscular and neuro-ventilatory coupling of the respiratory system during exercise in healthy adults: Implications for dyspnea and exercise tolerance (2011) (42)
Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. (2008) (41)
Respiratory sensation and ventilatory mechanics during induced bronchoconstriction in spontaneously breathing low cervical quadriplegia. (2002) (41)
Effect of obesity on constant workrate exercise in hyperinflated men with COPD (2010) (41)
The Physicians' Practice Assessment Questionnaire on asthma and COPD. (2011) (39)
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease. (2017) (39)
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study. (2016) (38)
Maximal Inspiratory Pressure: Does the Choice of Reference Values Actually Matter? (2017) (38)
Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease. (2007) (37)
Physiological effects of roflumilast at rest and during exercise in COPD (2011) (37)
Emphysema on Thoracic CT and Exercise Ventilatory Inefficiency in Mild-to-Moderate COPD (2017) (37)
Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD (2016) (37)
Muscle blood-flow dynamics at exercise onset: do the limbs differ? (2006) (36)
Ventilatory Inefficiency and Exertional Dyspnea in Early Chronic Obstructive Pulmonary Disease (2017) (35)
Identification and definition of asthma–COPD overlap: The CanCOLD study (2020) (35)
Ventilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPD (2015) (34)
The need to research refractory breathlessness (2016) (33)
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. (2003) (33)
Chronic obstructive pulmonary disease in men and women: myths and reality. (2009) (33)
Abnormal sarcoplasmic reticulum Ca2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease. (2008) (32)
Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. (2007) (32)
The Pathophysiology of Dyspnea and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. (2019) (32)
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis (2018) (32)
The Continuum of Physiological Impairment during Treadmill Walking in Patients with Mild-to-Moderate COPD: Patient Characterization Phase of a Randomized Clinical Trial (2014) (32)
Physiological impairment in mild COPD (2016) (31)
Exercise Limitation in Chronic Obstructive Pulmonary Disease (2008) (31)
Differential detection of skeletal troponin I isoforms in serum of a patient with rhabdomyolysis: markers of muscle injury? (2002) (31)
Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD. (2015) (31)
Exercise Ventilation in COPD: Influence of Systolic Heart Failure (2016) (31)
Heart Failure Impairs Muscle Blood Flow and Endurance Exercise Tolerance in COPD (2016) (30)
Patterns of cardiopulmonary response to exercise in lung diseases (2007) (30)
Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial (2017) (29)
Factors associated with undiagnosed and overdiagnosed COPD (2016) (29)
Is sustained pharmacologic lung volume reduction now possible in COPD? (2006) (29)
Does impaired O2 delivery during exercise accentuate central and peripheral fatigue in patients with coexistent COPD-CHF? (2014) (28)
[Dynamic lung hyperinflation and its clinical implication in COPD]. (2008) (28)
Incorporating Lung Diffusing Capacity for Carbon Monoxide in Clinical Decision Making in Chest Medicine. (2019) (28)
Serotonergic antidepressant use and morbidity and mortality among older adults with COPD (2018) (28)
Current challenges in managing comorbid heart failure and COPD (2018) (28)
Chronic obstructive pulmonary disease in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. (2015) (28)
Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease (2018) (28)
The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment. (2004) (28)
Quantifying the shape of the maximal expiratory flow–volume curve in mild COPD (2015) (27)
Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD (2019) (27)
Inspiratory Constraints and Ventilatory Inefficiency Are Superior to Breathing Reserve in the Assessment of Exertional Dyspnea in COPD (2019) (27)
Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis. (2014) (26)
Differences in respiratory muscle activity during cycling and walking do not influence dyspnea perception in obese patients with COPD. (2014) (26)
Resting Physiological Correlates of Reduced Exercise Capacity in Smokers with Mild Airway Obstruction (2017) (26)
Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance (2006) (26)
Exercise intolerance in pulmonary arterial hypertension. The role of cardiopulmonary exercise testing. (2015) (26)
Does exercise test modality influence dyspnoea perception in obese patients with COPD? (2013) (25)
Effects of heart failure on cerebral blood flow in COPD: Rest and exercise (2016) (25)
Effects of human pregnancy and advancing gestation on respiratory discomfort during exercise (2007) (25)
Mechanisms of Dyspnea in COPD (2005) (25)
Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation. (2008) (24)
Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study. (2016) (24)
Quality Assurance of Spirometry in a Population-Based Study –Predictors of Good Outcome in Spirometry Testing (2014) (24)
Adverse cardiac events associated with incident opioid drug use among older adults with COPD (2017) (23)
New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients (2012) (23)
An Updated Definition and Severity Classification of COPD Exacerbations: The Rome Proposal. (2021) (22)
Older patients with COPD: benefits of exercise training. (1993) (22)
Unraveling the Causes of Unexplained Dyspnea: The Value of Exercise Testing. (2019) (21)
Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease (2019) (21)
Exercise Endurance in COPD Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and (2006) (21)
Measurement of Dyspnea: Clinical Ratings (2005) (21)
The effects of marijuana smoking on lung function in older people (2019) (21)
Effect of age-related ventilatory inefficiency on respiratory sensation during exercise (2015) (21)
Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches (2010) (20)
Oxygen delivery-utilization mismatch in contracting locomotor muscle in COPD: peripheral factors. (2015) (20)
Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study. (2019) (20)
Sensory-mechanical relationships during high-intensity, constant-workrate exercise in COPD: J Appl Physiol 2006;101:1025–35. (2006) (20)
Pharmacological management of breathlessness in COPD: recent advances and hopes for the future (2016) (20)
Bronchodilator Responsiveness and Reported Respiratory Symptoms in an Adult Population (2013) (20)
Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention (2013) (19)
The role of evaluating inspiratory constraints and ventilatory inefficiency in the investigation of dyspnea of unclear etiology. (2019) (19)
Clinical and Physiologic Implications of Negative Cardiopulmonary Interactions in Coexisting Chronic Obstructive Pulmonary Disease-Heart Failure. (2019) (19)
Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio? (2019) (19)
A frame of reference for assessing the intensity of exertional dyspnoea during incremental cycle ergometry (2020) (19)
Recent advances in pharmacotherapy for dyspnea in COPD. (2011) (19)
EFFECT OF FLUTICASONE PROPIONATE/SALMETEROL 250/50 ON LUNG HYPERINFLATION AND EXERCISE ENDURANCE IN PATIENTS WITH COPD (2005) (19)
Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease (2015) (18)
Exercise intolerance in comorbid COPD and heart failure: the role of impaired aerobic function (2019) (18)
Ventilation Heterogeneity in Never-smokers and COPD:: Comparison of Pulmonary Functional Magnetic Resonance Imaging with the Poorly Communicating Fraction Derived From Plethysmography. (2016) (18)
The Integrative Physiology of Exercise Training in Patients with COPD (2019) (18)
Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD. (2011) (18)
Muscle fiber type characteristics in females with chronic obstructive pulmonary disease. A preliminary study (2009) (17)
Physiological and sensory consequences of exercise oscillatory ventilation in heart failure-COPD. (2016) (17)
McArdle's disease presenting as unexplained dyspnea in a young woman. (2004) (17)
Impaired exercise ventilatory efficiency in smokers with low transfer factor but normal spirometry (2017) (16)
Performance During Constant Workrate Cycling Exercise in Women with COPD and Hyperinflation (2009) (16)
The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations? (2016) (16)
Lung hyperinflation in COPD: the impact of pharmacotherapy (2006) (16)
Examining the Role of Activity, Exercise, and Pharmacology in Mild COPD (2014) (15)
Breathing at extremes: the restrictive consequences of super- and super-super obesity in men and women. (2020) (15)
Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD. (2013) (15)
Dyspnea in advanced chronic obstructive pulmonary disease. (1998) (14)
Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease (2017) (14)
Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers (2016) (14)
Exercise Tolerance According to the Definition of Airflow Obstruction in Smokers. (2020) (14)
Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema (2020) (13)
Low Resting Diffusion Capacity, Dyspnea and Exercise Intolerance in COPD. (2019) (13)
Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease. (2017) (13)
Mild chronic obstructive pulmonary disease: why spirometry is not sufficient! (2017) (13)
Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD (2018) (12)
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee (2019) (12)
The Role of Tiotropium Bromide, a Long-Acting Anticholinergic Bronchodilator, in the Management of COPD (2005) (12)
Mechanisms of activity-related breathlessness in healthy human pregnancy (2009) (12)
The increased ventilatory response to exercise in pregnancy reflects alterations in the respiratory control systems ventilatory recruitment threshold for CO2 (2010) (11)
Dyspnea : Mechanisms, Measurement, and Management, Third Edition (2014) (11)
Clinical Interpretation of Cardiopulmonary Exercise Testing: Current Pitfalls and Limitations (2021) (10)
Dyspnea and Exercise Limitation in Mild COPD: The Value of CPET (2020) (10)
The Lung Function Laboratory to Assist Clinical-Decision Making in Pulmonology: Evolving Challenges to an Old Issue. (2020) (10)
The enigma of dyspnoea in COPD: A physiological perspective (2019) (10)
Smoking, activity level and exercise test outcomes in a young population sample without cardiopulmonary disease. (2015) (10)
Oxygen supplementation during exercise improves leg muscle fatigue in chronic fibrotic interstitial lung disease (2021) (10)
How we do it - Using cardiopulmonary exercise testing to understand dyspnea and exercise intolerance in respiratory disease. (2022) (9)
Adult survivors of preterm birth. What spirometry conceals, exercise tests reveal. (2014) (9)
CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise. (2017) (9)
Systemic vascular dysfunction is associated with emphysema burden in mild COPD. (2018) (9)
Exertional dyspnoea–ventilation relationship to discriminate respiratory from cardiac impairment (2019) (8)
Morbidity and mortality associated with prescription cannabinoid drug use in COPD (2020) (8)
Deterioration of Nighttime Respiratory Mechanics in COPD (2020) (8)
The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease (2011) (8)
VENTILATORY AND PERCEPTUAL RESPONSES TO CYCLE EXERCISE IN OBESE FEMALES Authors (2007) (8)
Reduced exercise tolerance in mild chronic obstructive pulmonary disease: The contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency (2021) (8)
Influence of exertional hypoxemia on cerebral oxygenation in fibrotic interstitial lung disease (2020) (8)
The need to address increasing opioid use in elderly COPD patients (2016) (7)
Impact of a Specialized Ambulatory Clinic on Refractory Breathlessness in Subjects With Advanced COPD (2019) (7)
Evaluation of Dynamic Respiratory Mechanical Abnormalities During Conventional CPET (2020) (7)
The gap between indicated and prescribed stroke prevention therapies in a high-risk geriatric population (2017) (7)
Sensory-mechanical effects of a dual bronchodilator and its anticholinergic component in COPD (2018) (7)
Multidimensional breathlessness response to exercise: Impact of COPD and healthy ageing (2021) (7)
Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD (7)
Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD. (2019) (7)
Influence of heart failure on resting lung volumes in patients with COPD (2016) (7)
Cardiopulmonary Exercise Testing (2013) (7)
Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study (2017) (7)
Happy hypoxemia, or blunted ventilation? (2021) (6)
Impaired Ventilatory Efficiency, Dyspnea and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study. (2022) (6)
Deterioration of Nighttime Respiratory Mechanics in Chronic Obstructive Pulmonary Disease: Impact of Bronchodilator Therapy. (2020) (6)
BOOMR: Better Coordinated Cross-Sectoral Medication Reconciliation for Residential Care. (2017) (6)
Obesity: how pulmonary function tests may let us down (2020) (6)
Elevated exercise ventilation in mild COPD is not linked to enhanced central chemosensitivity (2020) (6)
Hemopneumothorax in a COPD patient treated with noninvasive positive pressure ventilation: the risk of attendant anticoagulation. (2004) (6)
Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses (2020) (6)
Insights into ventilation–gas exchange coupling in chronic thromboembolic pulmonary hypertension (2016) (6)
The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study (2021) (6)
Commentaries on Viewpoint : The two-hour marathon : Who and when ? (2010) (6)
Qualitative Components of Dyspnea during Incremental Exercise across the COPD Continuum (2021) (6)
Cardiopulmonary and Muscular Interactions: Potential Implications for Exercise (In)tolerance in Symptomatic Smokers Without Chronic Obstructive Pulmonary Disease (2019) (6)
Increasing Physical Activity in Chronic Obstructive Pulmonary Disease One Step at a Time. (2018) (6)
On the complexities of measuring exercise “ventilatory efficiency” in obstructive lung diseases (2020) (6)
Integrating measurements of pulmonary gas exchange to answer clinically relevant questions (2020) (5)
Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation. (2019) (5)
Effect of tiotropium on spontaneous expiratory flow–volume curves during exercise in GOLD 1-2 COPD (2013) (5)
Inspiratory muscle training reduces respiratory neural drive (RND) during exercise in patients with COPD (2014) (5)
Excess ventilation and exertional dyspnoea in heart failure and pulmonary hypertension (2022) (5)
Lung Function Testing in Chronic Obstructive Pulmonary Disease. (2020) (5)
Ventilation/Perfusion Mismatch: A Novel Target for COPD Treatment. (2022) (5)
Update on Nonsurgical Lung Volume Reduction Procedures (2016) (5)
Ambient Air Pollution and Dysanapsis: Associations with Lung Function and COPD in the CanCOLD Study. (2022) (5)
Excess ventilation in COPD: Implications for dyspnoea and tolerance to interval exercise (2018) (5)
Transfer coefficient of the lung for carbon monoxide and the accessible alveolar volume: clinically useful if used wisely (2019) (5)
Opioids in COPD: a cause of death or a marker of illness severity? (2016) (5)
Neuralgic amyotrophy: A rare cause of bilateral diaphragmatic paralysis. (1998) (5)
Lung Function And Exercise Impairment In Patients With GOLD Stage I And II COPD (2012) (5)
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications (2021) (5)
Effects of bi-level positive airway pressure on ventilatory and perceptual responses to exercise in comorbid heart failure-COPD (2019) (4)
Neurobiology of Dyspnea: An Overview (2014) (4)
Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study (2019) (4)
A Simplified Approach to Select Exercise Endurance Intensity for Interventional Studies in COPD (2018) (4)
Mechanisms of dyspnoea relief following radiation treatment in a patient with severe COPD (2011) (4)
Incident opioid use is associated with risk of respiratory harm in non-palliative COPD (2017) (4)
Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl (2020) (4)
Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial (2020) (4)
Mechanisms of orthopnoea in patients with advanced COPD (2019) (4)
Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study (2021) (4)
The Role of Spirometry in Evaluating Therapeutic Responses in Advanced COPD (2007) (3)
Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients (2016) (3)
Resting V′E/V′CO2 adds to inspiratory capacity to predict the burden of exertional dyspnoea in COPD (2020) (3)
Maximal inspiratory pressure: does the choice of reference values matter? (2016) (3)
Effect Of Indacaterol On Exercise Endurance In Patients With Moderate-to-severe COPD (2010) (3)
Physiological basis of dyspnoea (2005) (3)
Heart, lungs, and muscle interplay in worsening activity-related breathlessness in advanced cardiopulmonary disease. (2020) (3)
Cost Impact of a Pharmacist-Driven Medication Reconciliation Program during Transitions to Long-Term Care and Retirement Homes. (2020) (3)
Exertional dyspnoea in patients with mild‐to‐severe chronic obstructive pulmonary disease: neuromechanical mechanisms (2022) (3)
Why Clinical Physiology Remains Vital in the Modern Era. (2019) (3)
Compensatory responses to increased mechanical abnormalities in COPD during sleep (2022) (3)
The Impact of Obesity on Pulmonary Function Measurements in Patients with COPD across GOLD Stages. (2009) (3)
Pulmonary artery wedge pressure and exercise oscillatory ventilation in pre-capillary pulmonary hypertension. (2016) (3)
Recent Advances in the Physiological Assessment of Dyspneic Patients with Mild COPD (2021) (3)
Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial (2020) (3)
Effect of inspiratory muscle training (IMT) on static and dynamic respiratory muscle function in patients with COPD (2017) (3)
Arterial blood gases in the differential diagnosis of hypoxemia. (2020) (3)
Chronic Obstructive Pulmonary Disease in Men and Women (2012) (3)
Mechanisms of Exertional Dyspnea in Patients with Mild COPD and a Low Resting DLCO (2021) (3)
Can an 86-year-old woman with advanced lung disease be a world class athlete? (2012) (3)
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC (2016) (3)
Physiological and perceptual responses to exercise according to locus of symptom limitation in COPD (2020) (3)
Heart or Lungs? Uncovering the Causes of Exercise Intolerance in a Patient with Chronic Cardiopulmonary Disease. (2018) (2)
Long‐Acting Muscarinic Antagonists in Asthma and COPD (2012) (2)
The clinical physiology and integrative neurobiology of dyspnea: Introduction to the Special Issue of Respir. Physiol. Neurobiol. (2009) (2)
Effect of Bronchodilators and Inhaled Corticosteroids on Dyspnea in COPD (2005) (2)
Effects Of Dead Space Loading On The Intensity, Quality And Unpleasantness Of Perceived Respiratory Discomfort During Incremental Cycle Exercise In The Healthy Elderly (2010) (2)
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. (2003) (2)
Lung Hyperinflation in COPD: Mechanisms, Clinical Implications and Treatment (2015) (2)
Mechanisms of exertional dyspnea in patients with mild COPD and low resting lung diffusing capacity for carbon monoxide (DLCO) (2020) (2)
The Hospital Burden Of COPD In Canada (2010) (2)
Cellular assessment of muscle in COPD: case studies of two males (2009) (2)
Impact of bronchodilator therapy on diaphragmatic function in sleep in COPD (2020) (2)
Why we should never ignore an “isolated” low lung diffusing capacity (2019) (2)
Out-of-proportion dyspnea and exercise intolerance in mild COPD (2021) (2)
Exposing Pre-COPD: When Physiology Matters! (2021) (2)
Mechanisms of Dyspnea in Restrictive Lung Disease (2005) (2)
A Comparison Of The Mechanical And Sensory Consequences Of Dead Space Loading During Exercise In Mild COPD And In Health (2012) (2)
A 56-Year-Old, Otherwise Healthy Woman Presenting With Light-headedness and Progressive Shortness of Breath. (2016) (2)
Roflumilast Improves Lung Function and Quality of Life in Chronic Obstructive Pulmonary Disease (2004) (2)
Dyspnea and exercise intolerance in breast cancer survivors: The role of inspiratory muscle weakness (2015) (2)
Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study (2022) (2)
When obesity and COPD collide: Physiological and clinical consequences (2011) (2)
Are the “critical” inspiratory constraints actually decisive to limit exercise tolerance in COPD? (2020) (2)
The impact of human pregnancy on perceptual responses to chemoreflex vs. exercise stimulation of ventilation: A retrospective analysis (2011) (2)
Severe Exertional Dyspnea in an Ex-Smoker with a Large Apical Bulla. (2018) (2)
What is unique about the new Canadian COPD guidelines? (2004) (2)
Inhaled Fentanyl Citrate Improves Dynamic Airway Function, Exertional Dyspnea And Exercise Endurance In COPD (2011) (2)
Severe exertional dyspnea in a patient with localized emphysema. (1999) (1)
Impact Of Inhaled Fluticasone/Salmeterol Combination On Respiratory Physiology In Patients With Milder COPD (2011) (1)
Localised upper airway obstruction in a patient with acquired immunodeficiency syndrome. (1998) (1)
Inspiratory neural drive and muscle activity during sleep in moderate-to-severe COPD (2020) (1)
Integrating the Whole: Cardiopulmonary Exercise Testing (2018) (1)
Mechanisms of Dyspnea during Exercise in Chronic Obstructive Pulmonary Disease (2014) (1)
Ventilatory assistance decreases mechanical-inspiratory constraints and improves exercise tolerance in overlapping COPD-heart failure (2018) (1)
he increased ventilatory response to exercise in pregnancy reflects alterations n the respiratory control systems ventilatory recruitment threshold for CO 2 (2010) (1)
Measurement of Dyspnea Ratings During Exercise (2005) (1)
Sleep quality and architecture in COPD: the relationship with lung function abnormalities (2021) (1)
Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors. (2003) (1)
Weaning the “difficult-to-wean” patient (2004) (1)
Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue? (2020) (1)
Effects of acute dual bronchodilator treatment (tiotropium + olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD (2018) (1)
Activity-Related Dyspnoea in Chronic Pulmonary Diseases: New Mechanistic Insights (2017) (1)
chemoreflex response to carbon dioxide Effects of human pregnancy on the ventilatory (2005) (1)
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study (2013) (1)
Predictors of Opioid-related Adverse Pulmonary Events among Older Adults with COPD. (2020) (1)
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study (2014) (1)
Resting physiological markers of exercise intolerance in smokers with mild airway obstruction (2016) (1)
The clinician/scientist in respirology--a vanishing phenotype! (2010) (1)
Right ventricular dimensions during COPD exacerbations: A matter of low preload versus high afterload? (2021) (1)
Severe exertional dyspnoea in COPD: Implications for exercise tolerance and survival (2021) (1)
Overnight deterioration of supine respiratory mechanics in COPD: impact of nocturnal aclidinium bromide/formoterol fumarate (2019) (1)
Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry (2019) (1)
Pharmacological Treatment in Chronic Obstructive Pulmonary Disease (2008) (1)
Utility Of The COPD Assessment Test (CAT) In Predicting A Diagnosis Of COPD (2012) (1)
dead space loading in exercising men Respiratory sensation during chest wall restriction and (2015) (1)
Impact of Obesity and Gender on Perception of Dyspnea during Induced Bronchoconstriction and Dynamic Lung Hyperinflation in Asthma. (2009) (1)
The physiology and pathophysiology of exercise hyperpnea. (2022) (1)
Sex Differences in Physical Activity Levels and Dyspnea in Mild-to-Moderate COPD (2013) (1)
Perceived Locus of Symptom Limitation during Constant Work Rate Cycle Ergometry in COPD Patients Treated with Tiotropium (2004) (1)
Effect of Bronchodilators and Inhaled Corticosteroids on Dyspnea in Chronic Obstructive Pulmonary Disease (2014) (1)
Static and Dynamic Hyperinflation in Chronic Obstructive Pulmonary Disease (2014) (1)
Research officially recognized as a core activity of The Lung Association. (2010) (1)
Editorial: Clinical Cardiopulmonary Exercise Testing (2021) (1)
Pulmonary edema in athletes: methodology or meaningful physiology? (2010) (1)
The Impact Of Critical Volume Constraints During Exercise On The Evolution Of The Intensity And Quality Of Exertional Dyspnea In Advanced COPD (2010) (1)
Mechanisms and consequences of exertional dyspnoea in combined pulmonary fibrosis and emphysema (CPFE) (2019) (1)
Exposing Pre–Chronic Obstructive Pulmonary Disease: When Physiology Matters! (2021) (1)
LABA/LAMA combination, exercise and lung hyperinflation in COPD: a meta-analysis (2017) (1)
A combination of calcitonin and bisphosphonate for the emergency treatment of severe tumor-induced hypercalcemia (2004) (1)
Influence of systolic heart failure on exercise PETCO2in COPD (2016) (0)
Exacerbations in non-COPD patients: truth or myth—authors’ response (2014) (0)
A simple approach for assessing leg muscle oxygenation during incremental exercise in fibrotic interstitial lung disease (2022) (0)
Skeletal muscle oxygen delivery in COPD: The impact of coexistent heart failure (2014) (0)
Exertional dyspnea in COPD: the dominant role of increased diaphragmatic activation (2020) (0)
“Mild” COPD: What Spirometry Conceals! (2017) (0)
Dyspnea And Exercise Intolerance In COPD: Are Dynamic Hyperinflators Different From Non-Hyperinflators? (2012) (0)
Who and when? Commentaries on Viewpoint: The two-hour marathon: (2011) (0)
Physiological Predictors of Morbidity and Mortality in COPD: The Relative Importance of Reduced Inspiratory Capacity and Inspiratory Muscle Strength. (2022) (0)
Submaximal breathing reserve during incremental cycle ergometry: reference values and clinical validation (2022) (0)
dynamic hyperinflation during exercise in COPD patients with and without Heliox increases quadriceps muscle oxygen delivery (2015) (0)
Dr Ralph Beverly Lynn, 1921–2006 (2007) (0)
Predictors of Opioid-Related Adverse Pulmonary and Cardiac Events Among Older Adults with COPD (2020) (0)
Ventilatory Demand During Stepping and Running: Implications for Exercise-Induced Bronchoconstriction in Children (2019) (0)
Improvement In Exertional Dyspnea And Cycle Exercise Endurance With Short-Term Administration Of Inhaled Corticosteroid Monotherapy In Patients With COPD (2011) (0)
Neuromuscular dissociation of the diaphragm is more pronounced during treadmill exercise compared with cycle exercise in obese COPD patients (2014) (0)
The link between low resting diffusion capacity and exercise intolerance in COPD (2019) (0)
The Spread of the Better Coordinated Cross-Sectoral Medication Reconciliation (BOOMR) for Residential Care (2017) (0)
Health Status In Mild To Moderate Chronic Obstructive Pulmonary Disease (COPD) Subjects Sampled From A General Population (2012) (0)
Bronchodilators do not change ventilatory efficiency during exercise in COPD (2017) (0)
A pragmatic approach to establish an acceptable work rate to assess the effect of interventions on exercise endurance in COPD (2017) (0)
Neuromechanical uncoupling of the respiratory system during exercise in patients with mild COPD (2013) (0)
Comparison of gender-related risk factors for COPD - Results from the Canadian obstructive lung disease (CanCOLD) study (2013) (0)
Probing the old lung: challenges to pulmonary function testing interpretation in the elderly (2022) (0)
Bronchodilator therapy in COPD: physiological effects (2008) (0)
Do COPD patients with only mild-to-moderate airflow obstruction present with endothelial dysfunction? (2016) (0)
Absence of airflow obstruction on spirometry: can it still be COPD? (2021) (0)
Physiological phenotypes of COPD: the role of resting lung volumes (2020) (0)
Critical inspiratory constraints and excess ventilation are superior to breathing reserve in predicting exertional dyspnoea in COPD (2019) (0)
Cardiovascular Comorbidity in Chronic Lung Disease: The Role of Cardiopulmonary Exercise Testing (2020) (0)
Effects of Increased Chemostimulation on the Relationship Between Increasing Breathlessness Intensity and Increasing Neural Respiratory Motor Drive (Diaphragm EMG) During Exercise in Healthy Older Humans (2010) (0)
Effects of umeclidinium/vilanterol (UME/VIL) versus umeclidinium (UME) on exertional dyspnea and respiratory mechanics in moderate COPD (2017) (0)
Calculating the statistical limits of normal and Z-scores for pulmonary function tests (2022) (0)
Is Minimally Invasive Outpatient Pneumonectomy the Current Standard of Care for Lung Cancer ? (1999) (0)
Prevalence, Risk Factors, And Health Outcomes Of Obese And Underweight Population Cohorts With Chronic Obstructive Pulmonary Disease (COPD) (2011) (0)
Inspiratory muscle weakness in mildly- to moderately-hyperinflated patients with COPD (2014) (0)
Is cardiopulmonary exercise test useful to indicate heart failure in patients with COPD (2015) (0)
Vocal cord paralysis and respiratory muscle weakness: an unusual presentation of chronic polyneuropathy. (1998) (0)
The link between elevated inspiratory neural drive, inspiratory constraints, and dyspnea across the continuum of COPD severity (2022) (0)
Validating RespMech: an automated, free and open-source platform for respiratory mechanics analysis at rest and in exercise (2022) (0)
Functional Impairment in Smokers According to Differing Spirometric Criteria for COPD Diagnosis: Rest and Exercise (2020) (0)
Volume Reduction Surgery in Patients with Chronic Airflow Limitation: A Physiological Rationale (1996) (0)
LUNG HYPERINFLATION IN COPD : What the Clinician Needs to Know (2016) (0)
Multidimensional Evaluation Of Perceived Respiratory Discomfort During Incremental Cycle Exercise In Health And COPD (2011) (0)
A New Comprehensive Approach To Measuring Dyspnea In Response To Pulmonary Rehabilitation In COPD (2012) (0)
Longitudinal Changes In Lung Volume Measurements In Patients With Varying COPD Severity (2012) (0)
Optimizing bronchodilation in chronic obstructive pulmonary disease: is it possible? (2010) (0)
in healthy men and women Chemoreflex control of breathing during wakefulness (2005) (0)
Evaluating Long Term Care Homes’ IntraVenous Therapy Experiences (LIVE Study) (2017) (0)
Is the men's marathon world record 25 years behind the women's record? (2011) (0)
Quantification of oxygen exchange inefficiency in interstitial lung disease (2021) (0)
Physical Activity and Symptom Burden in COPD: The Canadian Obstructive Lung Disease (CanCOLD) Study. (2022) (0)
locomotor muscles is inadequate energy supply to the respiratory and The major limitation to exercise performance in COPD (2015) (0)
Erratum to: Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention (2013) (0)
Unraveling the Cause of Severe Exertional Dyspnea in a Heavy Smoker. (2017) (0)
during exercise in patients with COPD Metabolic and hemodynamic responses of lower limb (2015) (0)
A frame of reference for assessing the intensity of exertional dyspnoea during incremental cycle ergometry in men and women, aged 20 to 85 (2020) (0)
Update on nonsurgical lung volume reduction procedures. (2015) (0)
Symptomatic COPD : Is Spirometry Useful ? Assessment of Bronchodilator Efficacy in (2000) (0)
Oral Anticoagulants for the Management of Atrial Fibrillation in Long Term Care: A Quality Improvement Initiative (2017) (0)
Mechanisms of Exertional Dyspnea in Obesity: 192 (2009) (0)
Breathing too much! Ventilatory inefficiency and exertional dyspnea in pulmonary hypertension (2022) (0)
Oxygen delivery-utilization mismatch in contracting locomotor muscle in COPD : 1 peripheral factors 2 3 4 (2014) (0)
Chronic respiratory diseases: The dawn of precision rehabilitation (2019) (0)
Prioritizing research at the Canadian Thoracic Society and beyond. (2010) (0)
Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis (2018) (0)
Lung function: what constitutes (ab)normality? (2022) (0)
Obesity and Exercise Tolerance in COPD. (2009) (0)
Associations between lung diffusion impairment, ventilatory inefficiency and exercise intolerance in mild to very severe COPD (2016) (0)
Small airway disease: when the “silent zone” speaks up (2022) (0)
Impact of nebulized fentanyl on exertional dyspnea in interstitial lung disease (2019) (0)
Is ventilatory efficiency impaired during progressive exercise in mild COPD (2014) (0)
EFFECT OF GLYCOPYRRONIUM/INDACATEROL VERSUS TIOTROPIUM ON EXERTIONAL DYSPNEA DURING THE 3-MINUTE CONSTANT SPEED SHUTTLE TEST IN PATIENTS WITH COPD: THE RED TRIAL (2019) (0)
The severe asthma–obesity conundrum: Consequences for exertional dyspnoea and exercise tolerance in men and women (2022) (0)
Determinants and consequences of exercise ventilatory inefficiency in patients with COPD-heart failure overlap (2017) (0)
The Lung Association Leadership Conference--an opportunity for change. (2010) (0)
The Continuum of COPD Severity: Implications for Dyspnea, Respiratory Mechanics, and Exercise Capacity (2011) (0)
Respiratory Mechanical Constraints During Exercise In Patients With GOLD Stage I COPD (2010) (0)
(Mis)Interpreting changes in pulmonary function tests over time (2021) (0)
Physiologic Assessment of COPD (2011) (0)
Rev Mal Respir, 25 (2008), 1305 (2008) (0)
Impaired spirometry and chronic obstructive pulmonary disease increase the risk of cardiovascular disease: a Canadian cohort study. (2023) (0)
The Effects Of Combined COPD And Obesity On Respiratory Muscle Function During Exercise (2010) (0)
Significance of the endurance time to constant work rate cycling exercise. (2010) (0)
Descriptors of exertional dyspnea across the COPD severity spectrum (2016) (0)
Bi-level positive pressure ventilation increases exertional inspiratory capacity and improves breathlessness in heart failure patients with co-morbid COPD (2017) (0)
Do the 2012 spirometric Global Lung Function Initiative equations accurately diagnose restriction in the extreme obese? (2019) (0)
Lung hyperinflation is related to poor sleep quality in patients with COPD (2017) (0)
COPD_A_285338 305..320 (2021) (0)
dynamicsrelationship to central cardiovascular onset of heavy-intensity exercise in patients with Kinetics of muscle deoxygenation are accelerated at the (2015) (0)
The Lower Limits Of Normal ( LLN) Of FEV1/FEV6 Is Not A Substitute For FEV1/FVC In Screening For Airway Obstruction- Results From The Canadian Obstructive Lung Disease ( COLD) Study (2012) (0)
Influence of heart failure on resting inspiratory volumes in patients with COPD (2016) (0)
Postural relief of dyspnea is associated with reduced neuromechanical dissociation in patients with advanced COPD (2022) (0)
Physiological determinants of reduced tolerance to interval exercise in moderate-to-severe COPD (2016) (0)
Reply: Effects of Mild Chronic Obstructive Pulmonary Disease on Gas Exchange during Cycling and Walking. (2015) (0)
Letter To The Editor (2010) (0)
Clinical utility of work-of-breathing measurements in COPD (2003) (0)
Non-invasive assessment of pulmonary microcirculation at rest and exercise in patients with previous pulmonary thromboembolism (2018) (0)
Exercise intolerance in untreated obstructive sleep apnea: role of pulmonary gas exchange and systemic vascular abnormalities. (2022) (0)
Respiratory Muscle Recruitment Patterns with Progression of COPD. (2009) (0)
Static Lung Volumes and Acute Bronchodilator Reversibility Patterns in a COPD Population: A Comparison across GOLD Stages. (2009) (0)
Effects of Metabolic Acidosis on the Ventilatory and Perceptual Response to Incremental Cycle Exercise in Healthy Humans (2010) (0)
Evaluating the Effects of a Long-Term Care Pharmacist Educator Component in a Family Medicine Residency Program (2016) (0)
Endurance Time During Constant Work Rate Cycle Ergometry in COPD: Development of an Integrated Database From Interventional Studies. (2022) (0)
Session: A Randomized Crossover Study Influence of Ambient Music on Perceived Exertion During a Pulmonary Rehabilitation (2015) (0)
Testing for exercise limitation in obstructive lung disease. (1999) (0)
The effects of COPD progression on exercise ventilatory inefficiency (2014) (0)
Is psychological stress associated with smoking and physical activity levels in patients in the CanCOLD Study (2017) (0)
Components of dyspnoea during incremental exercise across the COPD continuum (2021) (0)
Opioids for the Amelioration of Dyspnea in COPD: A Much Neglected Topic (2012) (0)
12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease. (2018) (0)
Relationship between ambient air pollution and lung function in a Canadian population: the CanCOLD cohort study (2020) (0)
Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease (2023) (0)
Structural determinants of exercise ventilatory inefficiency in mild-to-moderate COPD (2016) (0)
Is this asthma, COPD, or both? (2021) (0)
Characteristics Of COPD In Non-Smokers - Results From The Canadian Obstructive Lung Disease [COLD] Study (2012) (0)
Resting ventilation distribution abnormalities predict exercise impairment in mild to end-stage COPD (2014) (0)
Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort. (2023) (0)
Exertional Oxygen Supplementation Improves Leg Muscle Oxygenation and Neuromuscular Fatigue in Patients with Fibrotic Interstitial Lung Disease (2020) (0)
The continuum of COPD: a physiological perspective (2012) (0)
Cardiopulmonary exercise testing in the investigation of unexplained dyspnoea: the role of inspiratory constraints and ventilatory inefficiency (2019) (0)
Validating RespMech: an automated, free and open-source platform for diaphragmatic electromyography analysis at rest and in exercise (2022) (0)
pulmonary disease properties in skeletal muscle in chronic obstructive Abnormal sarcoplasmic reticulum Ca2+-sequestering (2008) (0)
Summer round-up (2010) (0)
The restrictive consequences of extreme obesity in men and women (2020) (0)
and exercise in COPD Effect of obesity on respiratory mechanics during rest (2011) (0)
Reliability and clinical relevance of impulse oscillometry in smokers with and without airflow obstruction (2022) (0)
Dietary nitrate supplementation and exercise tolerance in chronic heart failure: A double-blind, randomized, placebo-controlled, crossover trial (2016) (0)
Mechanisms of orthopnea in patients with advanced COPD (2019) (0)
Effects of systolic heart failure on cerebral oxygen delivery-to-utilization matching in COPD (2014) (0)
Reply to Topalovic and Janssens Re: Quantifying the shape of the maximal expiratory flow–volume curve to address flow limitation (2016) (0)
Predicting poor outcome in COPD-heart failure overlap: The role of resting echocardiography and cardiopulmonary exercise testing (2015) (0)
Do “static” lung volumes add to inspiratory capacity to predict exertional dyspnea and poor exercise tolerance in COPD? (2022) (0)
Assessment of Disability: What Test, or Combination of Tests, Should be Used? (2008) (0)
Superior Athletic Performance In An 86 Year Old Woman With Advanced Obstructive Lung Disease (2012) (0)
Radiation Induced Lung Volume Reduction and Dyspnea Relief in a Patient With Severe COPD (2011) (0)
The Role of Acid-Base Balance in the Chemoreflex Control of Breathing: Implications for Respiratory Sensation (2010) (0)
Getting the most out of the six-minute walk test. (2023) (0)
Chest radiotherapy to achieve lung volume reduction (2012) (0)
How does CHF influence the physiological and sensory responses to incremental exercise in patients with COPD (2014) (0)
James Stray-Gundersen performance acclimatization with low-altitude training on ' ' Living high-training low ' ' : effect of moderate-altitude (2016) (0)
Resting V?E / V?CO2 is a strong predictor of exertional dyspnoea in COPD (2019) (0)
Marijuana smoking: Health and socioeconomic impact in middle-aged and elderly adults (2016) (0)
Opioids in COPD: the ‘whole picture’ includes results from real‐world, population‐based observational studies (2016) (0)
Effects Of Dead Space Loading On The Ventilatory And Perceptual Response To Incremental Cycle Exercise In Healthy Elderly (60-80 Yr) Men And Women (2010) (0)
The effect of tiotropium on lung dynamic hyperinflation and treadmill exercise capacity in mild to moderate COPD (2012) (0)
Impaired cerebral oxygenation: a cause for exercise intolerance in patients with fibrotic interstitial lung disease? (2020) (0)
COPD severity and health impact across the current CanCOLD population (2012) (0)
Why patients with lung fibrosis showing only mild restriction at rest may develop limiting dyspnoea on exertion? (2022) (0)
Adverse cardiac events associated with incident opioid drug use among older adults with COPD (2017) (0)
Practical challenges of diagnosing obstruction in the presence of restriction (2019) (0)
Exercise ventilatory inefficiency is an independent predictor of mortality in COPD (2015) (0)
Effects of Human Pregnancy on the Intensity of Perceived Breathlessness during Hypercapnia-Induced Hyperventilation. (2009) (0)
Pulmonary Vascular Volume by Quantitative CT in Dyspneic Smokers with Minor Emphysema. (2023) (0)
Neurophysiological Mechanisms of Exertional Dyspnea in Post-Pulmonary Embolism Syndrome. (2023) (0)
Pathophysiology of Dyspnea in COPD 147 Chemical and Mechanical Loads : What Have We Learned ? (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Denis Eunan O'donnell?

Denis Eunan O'donnell is affiliated with the following schools:

Queen's University at Kingston